Your browser is no longer supported. Please, upgrade your browser.
Surmodics, Inc.
Index- P/E1242.17 EPS (ttm)0.05 Insider Own3.30% Shs Outstand13.67M Perf Week1.71%
Market Cap793.10M Forward P/E59.03 EPS next Y0.97 Insider Trans-5.34% Shs Float13.27M Perf Month4.02%
Income0.70M PEG124.22 EPS next Q0.63 Inst Own89.80% Short Float2.66% Perf Quarter28.81%
Sales94.50M P/S8.39 EPS this Y-85.20% Inst Trans0.23% Short Ratio6.68 Perf Half Y42.78%
Book/sh9.76 P/B5.85 EPS next Y159.52% ROA0.40% Target Price70.75 Perf Year71.18%
Cash/sh3.88 P/C14.71 EPS next 5Y10.00% ROE0.50% 52W Range33.00 - 58.60 Perf YTD31.30%
Dividend- P/FCF108.64 EPS past 5Y-38.20% ROI1.00% 52W High-2.49% Beta1.06
Dividend %- Quick Ratio6.00 Sales past 5Y8.90% Gross Margin83.20% 52W Low73.15% ATR2.02
Employees370 Current Ratio6.50 Sales Q/Q-1.30% Oper. Margin-1.00% RSI (14)61.87 Volatility3.45% 3.81%
OptionableYes Debt/Eq0.00 EPS Q/Q-286.50% Profit Margin0.70% Rel Volume0.58 Prev Close57.67
ShortableYes LT Debt/Eq0.00 EarningsFeb 09 BMO Payout0.00% Avg Volume52.90K Price57.14
Recom1.50 SMA204.56% SMA509.51% SMA20028.23% Volume30,820 Change-0.92%
Jul-23-20Upgrade Needham Hold → Buy
Dec-11-19Downgrade Needham Buy → Hold
Nov-01-19Downgrade Lake Street Buy → Hold $75 → $50
Aug-01-19Reiterated Needham Buy $65 → $68
May-02-19Reiterated Needham Buy $74 → $65
May-02-19Reiterated Lake Street Buy $90 → $75
Feb-21-19Reiterated Needham Buy $69 → $74
May-16-18Reiterated Needham Buy $46 → $55
Mar-01-18Upgrade Sidoti Neutral → Buy
Feb-28-18Reiterated Lake Street Buy $35 → $38
Feb-28-18Initiated Needham Buy $42
Jul-14-17Initiated Lake Street Buy $40
Nov-21-16Downgrade Barrington Research Outperform → Mkt Perform
Oct-06-16Downgrade Sidoti Buy → Neutral
May-03-16Reiterated Barrington Research Outperform $27 → $30
Aug-06-15Reiterated Barrington Research Outperform $28 → $29
Mar-27-15Initiated Dougherty & Company Buy $33
Feb-25-14Initiated Laidlaw Buy $30
Aug-01-13Upgrade Feltl & Co. Buy → Strong Buy $31.25
Nov-12-12Reiterated Barrington Research Outperform $20 → $22
Apr-07-21 11:40AM  
Apr-06-21 01:07PM  
Apr-01-21 08:42AM  
Mar-31-21 12:26PM  
Mar-30-21 12:19PM  
Mar-23-21 07:30PM  
Mar-17-21 04:05PM  
Mar-16-21 12:20PM  
Feb-10-21 11:31AM  
Feb-09-21 04:00PM  
Feb-05-21 08:12AM  
Feb-04-21 08:30AM  
Feb-02-21 12:31PM  
Feb-01-21 08:30AM  
Jan-25-21 08:25AM  
Jan-20-21 11:40AM  
Jan-12-21 08:05AM  
Dec-16-20 10:28AM  
Dec-04-20 11:31AM  
Nov-09-20 08:05AM  
Nov-05-20 09:13AM  
Nov-04-20 06:05PM  
Oct-28-20 12:32PM  
Oct-27-20 08:30AM  
Oct-22-20 12:33PM  
Oct-12-20 11:40AM  
Sep-29-20 09:06AM  
Sep-23-20 08:30AM  
Sep-15-20 08:20AM  
Sep-04-20 11:31AM  
Aug-10-20 08:17AM  
Aug-07-20 11:39AM  
Aug-05-20 06:15PM  
Jul-29-20 12:33PM  
Jul-28-20 08:30AM  
Jul-22-20 12:32PM  
Jul-14-20 11:40AM  
Jul-08-20 08:39AM  
Jul-05-20 05:45PM  
Jul-01-20 08:49AM  
Jun-30-20 06:57AM  
Jun-29-20 10:12AM  
Jun-26-20 09:09AM  
Jun-25-20 07:53AM  
Jun-23-20 09:24AM  
Jun-17-20 06:28AM  
Jun-16-20 08:45AM  
Jun-12-20 12:20PM  
Jun-10-20 09:50AM  
Jun-09-20 08:02AM  
Jun-08-20 08:30AM  
Jun-03-20 10:07AM  
Jun-02-20 11:11AM  
Jun-01-20 09:59AM  
May-29-20 11:31AM  
May-28-20 09:43AM  
May-27-20 10:03AM  
May-26-20 10:02AM  
May-20-20 07:43AM  
May-19-20 10:47AM  
May-18-20 11:55AM  
May-14-20 08:30AM  
May-01-20 10:31AM  
Apr-30-20 09:24PM  
Apr-29-20 07:05PM  
Apr-27-20 08:28AM  
Apr-22-20 12:31PM  
Apr-21-20 02:10PM  
Apr-20-20 08:27AM  
Apr-15-20 08:26AM  
Apr-09-20 09:35AM  
Apr-02-20 07:11AM  
Mar-21-20 10:54AM  
Mar-06-20 11:30AM  
Feb-20-20 09:54AM  
Feb-10-20 06:29PM  
Feb-06-20 10:03AM  
Feb-05-20 06:25PM  
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OLSON CHARLES WSenior VP of Bus Dev, Med DevMar 31Sale56.754,759270,07342,740Apr 02 02:30 PM
Maharaj Gary RPresident & CEOMar 01Sale52.064,000208,259164,713Mar 03 06:12 PM
KNIGHT SUSAN EDirectorFeb 26Option Exercise21.315,576118,82534,290Mar 02 04:06 PM
OLSON CHARLES WSenior VP of Bus Dev, Med DevFeb 26Option Exercise20.4613,533276,82756,638Mar 02 04:07 PM
KNIGHT SUSAN EDirectorFeb 26Sale52.365,576291,95528,714Mar 02 04:06 PM
Arens Timothy J.Chief Financial OfficerFeb 24Option Exercise20.4410,973224,24265,076Feb 26 04:02 PM
BEDOYA JOSE HDirectorFeb 23Sale50.681,49775,86822,817Feb 25 04:33 PM
Stich Joseph J.SVP, HR and GM, IVDFeb 16Sale51.692,500129,23748,062Feb 18 04:37 PM
KALICH RONALD B SRDirectorFeb 12Option Exercise26.464,098108,43323,504Feb 16 04:50 PM
Maharaj Gary RPresident & CEOFeb 11Option Exercise22.3682,2641,839,571224,406Feb 16 04:52 PM
Maharaj Gary RPresident & CEOFeb 01Sale44.813,000134,423142,142Feb 03 04:14 PM
Stich Joseph J.SVP, HR and GM, IVDJan 05Sale45.002,500112,50050,562Jan 07 04:37 PM
Maharaj Gary RPresident & CEOJan 04Sale43.962,00087,926145,142Jan 06 04:25 PM
BEDOYA JOSE HDirectorNov 17Option Exercise22.583,57580,72425,325Nov 19 05:06 PM
DANTZKER DAVIDDirectorNov 10Option Exercise22.583,57580,72430,471Nov 13 04:20 PM
Maharaj Gary RPresident & CEOSep 01Sale45.073,000135,206135,399Sep 03 05:06 PM
Stich Joseph J.SVP, HR and GM, IVDAug 19Sale46.712,500116,78151,570Aug 21 03:20 PM
Maharaj Gary RPresident & CEOAug 03Sale47.443,000142,334138,142Aug 05 04:28 PM
Stich Joseph J.SVP, HR and GM, IVDJul 22Option Exercise22.5812,612284,77963,488Jul 24 05:24 PM
Maharaj Gary RPresident & CEOJul 01Sale43.022,00086,037141,142Jul 06 06:10 PM
Stich Joseph J.SVP, HR and GM, IVDJun 09Sale45.002,500112,50051,499Jun 11 05:47 PM